Conversely, hormone-receptor-negative breast cancer comprises two distinct subtypes, the Her2 (human epidermal growth factor receptor 2) subtype and the basal-like subtype [11,12], which differ in biology and behavior, and are both associated with a poor outcome. This evidence concerns the gene ERBB2 and breast carcinoma.